Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammad Ahmed-Khan

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Mini Reviews in Medicinal Chemistry|July 24, 2015
Past, Present and Future of Antiepileptic Drug Therapy - Finding a Place for HeterocyclicsRuhi Ali, Mohammad Ahmed Khan, Nadeem Siddiqui
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 10, 2024
Significance of phosphoinositide 3-kinase inhibitors in advanced breast cancer: a systematic review and meta-analysisAsma Naqi, Mohammad Ahmed Khan, Abul Kalam Najmi
Current Drug Targets|February 17, 2025
Proteases and Osteoporosis: A Comprehensive Review of Their Role in Bone HealthSyed Sufian Ahmad, Faraha Ahmed, Sayeed Ahmad, et al.
Expert Opinion on Drug Delivery|January 26, 2026
Chitosan nanoparticles for brain targeted nose-to-brain drug delivery in neurodegenerative disease: a comprehensive exploration of advances, limitations and future prospectsMumtaz, Devika Unnithan, Hadiseh Hosseini, et al.
International Journal of Pharmaceutical Investigation|September 21, 2017
Compensation to clinical trial participants in India: A gap analysisMohd Urooj, Gulam Mohammed Husain, Mohammad Ahmed Khan, et al.
Journal of Pharmacy & Bioallied Sciences|December 19, 2015
Hepatoprotective potential of kumaryasava and its concentrate against CCl4-induced hepatic toxicity in Wistar ratsMohammad Ahmed Khan, Arun Gupta, J L N Sastry, et al.
Medical Oncology (Northwood, London, England)|October 8, 2022
Myricetin-induced apoptosis in triple-negative breast cancer cells through inhibition of the PI3K/Akt/mTOR pathwayPreeti Sharma, Mohammad Ahmed Khan, Abul Kalam Najmi, et al.
Journal of Ethnopharmacology|June 28, 2016
Pharmacological evidences for cytotoxic and antitumor properties of Boswellic acids from Boswellia serrataMohammad Ahmed Khan, Ruhi Ali, Rabea Parveen, et al.
Iranian Journal of Basic Medical Sciences|February 19, 2025
Targeting dipeptidyl peptidase-8/9 to combat inflammation-induced osteoclastogenesis in RAW264.7 macrophages and analysis of anti-osteoclastogenesis potential of chrysinSyed Sufian Ahmad, Faraha Ahmed, Sayeed Ahmad, et al.
Current Pharmaceutical Design|September 17, 2021
Recent Advances in Theranostic Applications of Nanomaterials in CancerFaraha Ahmed, Mohammad Ahmed Khan, Nafis Haider, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Mini Reviews in Medicinal Chemistry|July 24, 2015
Past, Present and Future of Antiepileptic Drug Therapy - Finding a Place for HeterocyclicsRuhi Ali, Mohammad Ahmed Khan, Nadeem Siddiqui
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 10, 2024
Significance of phosphoinositide 3-kinase inhibitors in advanced breast cancer: a systematic review and meta-analysisAsma Naqi, Mohammad Ahmed Khan, Abul Kalam Najmi
Current Drug Targets|February 17, 2025
Proteases and Osteoporosis: A Comprehensive Review of Their Role in Bone HealthSyed Sufian Ahmad, Faraha Ahmed, Sayeed Ahmad, et al.
Expert Opinion on Drug Delivery|January 26, 2026
Chitosan nanoparticles for brain targeted nose-to-brain drug delivery in neurodegenerative disease: a comprehensive exploration of advances, limitations and future prospectsMumtaz, Devika Unnithan, Hadiseh Hosseini, et al.
International Journal of Pharmaceutical Investigation|September 21, 2017
Compensation to clinical trial participants in India: A gap analysisMohd Urooj, Gulam Mohammed Husain, Mohammad Ahmed Khan, et al.
Journal of Pharmacy & Bioallied Sciences|December 19, 2015
Hepatoprotective potential of kumaryasava and its concentrate against CCl4-induced hepatic toxicity in Wistar ratsMohammad Ahmed Khan, Arun Gupta, J L N Sastry, et al.
Medical Oncology (Northwood, London, England)|October 8, 2022
Myricetin-induced apoptosis in triple-negative breast cancer cells through inhibition of the PI3K/Akt/mTOR pathwayPreeti Sharma, Mohammad Ahmed Khan, Abul Kalam Najmi, et al.
Journal of Ethnopharmacology|June 28, 2016
Pharmacological evidences for cytotoxic and antitumor properties of Boswellic acids from Boswellia serrataMohammad Ahmed Khan, Ruhi Ali, Rabea Parveen, et al.
Iranian Journal of Basic Medical Sciences|February 19, 2025
Targeting dipeptidyl peptidase-8/9 to combat inflammation-induced osteoclastogenesis in RAW264.7 macrophages and analysis of anti-osteoclastogenesis potential of chrysinSyed Sufian Ahmad, Faraha Ahmed, Sayeed Ahmad, et al.
Current Pharmaceutical Design|September 17, 2021
Recent Advances in Theranostic Applications of Nanomaterials in CancerFaraha Ahmed, Mohammad Ahmed Khan, Nafis Haider, et al.
Pageof 7